{"groups":[{"description":"500 mg/m\\^2 pemetrexed, IV infusion\n\nPemetrexed: Alvopem® was administered every 3 weeks with a dose of 500 mg/m\\^2","id":"FG000","title":"NanoAlvand Pemetrexed"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"199"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"198"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}